China's efforts to combine artificial intelligence with biotechnology are moving from computer models to laboratory experiments, as a national research facility has launched an automated platform ...

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

The decision supports stronger international participation, enhanced business opportunities and an impactful launch edition for the region's process industries, directly supporting Vision 2030's ...

In a paper published in Proceedings of the National Academy of Sciences, researchers from Technion and Tel Aviv University ...

With a lifelong passion for baseball and love of science, Jake Bruml began his career in biotech but transitioned to direct ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...

German engineering company GEA is relocating its Application and Technology Center for future food from Hildesheim to ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...